These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8641685)

  • 1. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia.
    Shaikh S; Collier DA; Sham PC; Ball D; Aitchison K; Vallada H; Smith I; Gill M; Kerwin RW
    Hum Genet; 1996 Jun; 97(6):714-9. PubMed ID: 8641685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.
    Scharfetter J; Chaudhry HR; Hornik K; Fuchs K; Sieghart W; Kasper S; Aschauer HN
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):17-20. PubMed ID: 10647091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.
    Szekeres G; Kéri S; Juhász A; Rimanóczy A; Szendi I; Czimmer C; Janka Z
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):1-5. PubMed ID: 14681904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
    Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
    Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.
    Kohn Y; Ebstein RP; Heresco-Levy U; Shapira B; Nemanov L; Gritsenko I; Avnon M; Lerer B
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):39-43. PubMed ID: 9088883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
    Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
    Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of association between the ser-9-gly polymorphism of the D3 dopaminergic receptor and schizophrenia].
    Cordeiro Q; Junqueira R; Vallada H
    Arq Neuropsiquiatr; 2001 Jun; 59(2-A):219-22. PubMed ID: 11400029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
    Rybakowski JK; Borkowska A; Czerski PM; Hauser J
    Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.
    Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia.
    Williams J; Spurlock G; Holmans P; Mant R; Murphy K; Jones L; Cardno A; Asherson P; Blackwood D; Muir W; Meszaros K; Aschauer H; Mallet J; Laurent C; Pekkarinen P; Seppala J; Stefanis CN; Papadimitriou GN; Macciardi F; Verga M; Pato C; Azevedo H; Crocq MA; Gurling H; Owen MJ
    Mol Psychiatry; 1998 Mar; 3(2):141-9. PubMed ID: 9577838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.
    Kaiser R; Könneker M; Henneken M; Dettling M; Müller-Oerlinghausen B; Roots I; Brockmöller J
    Mol Psychiatry; 2000 Jul; 5(4):418-24. PubMed ID: 10889553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population.
    Kremer I; Rietschel M; Dobrusin M; Mujaheed M; Murad I; Blanaru M; Bannoura I; Müller DJ; Schulze TG; Reshef A; Gathas S; Schwab S; Wildenauer D; Bachner-Melman R; Belmaker RH; Maier W; Ebstein RP
    Am J Med Genet; 2000 Dec; 96(6):778-80. PubMed ID: 11121180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response.
    Arranz MJ; Li T; Munro J; Liu X; Murray R; Collier DA; Kerwin RW
    Pharmacogenetics; 1998 Dec; 8(6):481-4. PubMed ID: 9918131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
    Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller HJ; Propping P; Nöthen MM
    Neuropsychopharmacology; 1996 Nov; 15(5):491-6. PubMed ID: 8914122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.
    Hwang R; Shinkai T; De Luca V; Müller DJ; Ni X; Macciardi F; Potkin S; Lieberman JA; Meltzer HY; Kennedy JL
    Psychopharmacology (Berl); 2005 Aug; 181(1):179-87. PubMed ID: 15830237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
    Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.
    Adams DH; Close S; Farmen M; Downing AM; Breier A; Houston JP
    Hum Psychopharmacol; 2008 Jun; 23(4):267-74. PubMed ID: 18320559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.